|
End-of-day quote
Shanghai S.E.
2026-09-01
|
5-day change | 1st Jan Change | ||
| 18.41 CNY | -0.22% |
|
+6.05% | +4.48% |
| 08-24 | DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.22% | +6.05% | -2.33% | +11.58% | +4.48% | +9.19% | -30.76% | -41.79% | - | 3.12B | ||
| -0.11% | -2.30% | -7.46% | -5.05% | -34.31% | -41.94% | -13.81% | -49.57% | - | 14.85B | ||
| -0.21% | +0.89% | +2.80% | +14.75% | -3.93% | -14.52% | -8.85% | +53.26% | +243.21% | 6.43B | ||
| -0.65% | -2.23% | -14.48% | -15.43% | -39.21% | -43.77% | -33.69% | -75.94% | -36.44% | 6.37B | ||
| +0.26% | -3.00% | +0.92% | +8.51% | +5.62% | -3.37% | -22.59% | -25.66% | +101.44% | 4.13B | ||
| +0.27% | -1.12% | -2.47% | -5.65% | -2.42% | -20.84% | -38.93% | - | - | 3.2B | ||
| -1.12% | -1.16% | -9.99% | -15.35% | -41.02% | -46.80% | -27.42% | -34.39% | +63.91% | 2.88B | ||
| -1.52% | +1.65% | -6.14% | -4.30% | -16.76% | -15.30% | -8.21% | +39.07% | +113.72% | 2.58B | ||
| +4.81% | +3.71% | -5.21% | -1.46% | +28.56% | +45.43% | - | - | - | 2.35B | ||
| -1.15% | -0.66% | -5.19% | -18.59% | -18.66% | -16.39% | +19.12% | -8.69% | - | 1.51B | ||
| -3.21% | -2.74% | -5.04% | +30.80% | -7.30% | -25.59% | -43.12% | -61.06% | - | 1.49B | ||
| +3.65% | +9.13% | +17.92% | +20.74% | +59.35% | +68.16% | +133.63% | +280.55% | +408.38% | 1.42B | ||
| -0.03% | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -9.32% | +5.54% | 1.14B | ||
| +1.61% | -0.87% | -2.91% | -2.07% | -11.90% | -22.87% | -50.02% | -62.33% | -51.06% | 952M | ||
| +1.50% | 0.00% | +5.30% | -15.97% | -19.77% | +7.90% | -30.87% | - | - | 873M | ||
| +0.73% | -0.92% | -4.68% | -19.61% | -22.44% | -40.42% | -59.52% | - | - | 870M | ||
| +0.12% | -0.52% | -4.53% | -24.82% | -16.63% | -20.06% | -17.05% | - | - | 849M | ||
| -1.61% | +1.59% | +3.80% | +6.03% | -17.05% | -24.68% | - | - | - | 845M | ||
| +0.82% | +6.43% | +2.96% | -1.81% | -7.93% | +12.23% | -31.86% | -23.66% | - | 813M | ||
| -3.55% | -4.08% | -5.49% | +4.90% | -28.83% | -22.08% | +35.77% | +37.09% | - | 699M | ||
| Average | +0.03% | +0.19% | -2.11% | -1.64% | -9.51% | -10.78% | -12.68% | +1.25% | +106.09% | 2.87B | |
| Weighted average by Cap. | -0.05% | -0.66% | -4.31% | -1.46% | -15.82% | -20.46% | -16.21% | -18.22% | +106.75% |
- Stock Market
- Stocks
- 603233 Stock
- Sector DaShenLin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















